Gene Editing Market Forecast 2025-2034: Evaluating Growth Factors, Segments, and Emerging Trends

Which drivers are expected to have the greatest impact on the over the gene editing market's growth?
The surge in the gene editing market is fuelled by the rising incidence of communicable diseases, rendering gene editing methods essential for their diagnosis and cure. Communicable diseases, those instigated by infectious elements like bacteria, viruses, or parasites, can be passed from an individual to another, animals, or the environment. The use of gene editing tools is on an incline to devise targeted strategies to detect and combat germs at a genetic level, thereby improving disease control and avoidance efforts. For instance, in 2023, The World Economic Forum, a Switzerland-based international non-governmental organization, recorded an increase in infections like influenza and respiratory syncytial virus (RSV) since the pandemic outbreak began. In the USA, there have been about 24 million illnesses, 260,000 hospitalizations, and 16,000 influenza-related deaths till February 2023. Furthermore, the World Health Organization reported in 2022 that a global count of 10.6 million individuals were infected with tuberculosis, with 1.3 million deaths linked to the disease. Hence, communicable diseases are propelling the gene editing market.

Get Your Gene Editing Market Report Here:
https://www.thebusinessresearchcompany.com/report/gene-editing-global-market-report

What is the future CAGR of the gene editing market, and how will it impact industry expansion?
In the past few years, there has been a significant increase in the size of the gene editing market. The market is projected to expand from $8.82 billion in 2024 to $10.34 billion in 2025, marking a compound annual growth rate (CAGR) of 17.3%. Factors like the discovery of CRISPR-Cas9, progress in genetic sequencing, advances in medical technology, support for scientific research, and the expansion of the biotech industry have all contributed to this historical growth.

Anticipated to witness a swift expansion in the coming years, the gene editing market is projected to attain a value of $20.79 billion by 2029, growing at a compound annual growth rate (CAGR) of 19.1%. This impending growth throughout the forecasted period can be ascribed to the broadening of therapeutic applications, improvements in precision and efficiency, the commercialization of gene therapy, the progression of agricultural applications, and the increase in regenerative medicine. The forecast period will also likely see several major trends such as breakthroughs in multiplex editing methods, innovations in base editing, gene drives and alterations in population, non-viral delivery systems, and advancements in disease modeling and drug discovery.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2486&type=smp

What are the most significant trends transforming the gene editing market today?
Prominent businesses in the gene editing markets are employing cutting-edge technologies, such as certain cell-penetrating peptides, to get ahead in the field. These developments could catalyze the creation of advanced treatments for diseases like cancer. Penn Medicine, a significant multi-hospital health system from the United States, discovered in April 2023 that some viruses use protein fragments to infiltrate cells and these could also help get CRISPR-Cas gene editing molecules into cells and their DNA-filled nuclei. This could happen with notable efficiency and minimal cellular toxicity. The technique is expected to be especially beneficial in altering T cells and other cells from patients to develop cell therapies. An example of its application can be seen in CAR T therapy (chimeric antigen receptor T cell), which uses specially altered immune cells from a patient to fight cancer. This new strategy for genetically modifying cells offers substantial enhancements in speed, efficiency, and cellular toxicity reduction over existing methods.

Which key market segments comprise the gene editing market and drive its revenue growth?
The gene editing market covered in this report is segmented -

1) By Technology: CRISPR, TALEN, ZFN
2) By Application: Animal Genetic Engineering, Plant Genetic Engineering, Cell Line Engineering
3) By End Users: Biotechnology, Pharmaceutical, Contract Research Organization

Subsegments:
1) By CRISPR: CRISPR-Cas9, CRISPR-Cas12, CRISPR-Cas13, CRISPR-based Gene Drives
2) By TALEN (Transcription Activator-Like Effector Nucleases): Custom TALENs, Commercial TALEN Kits
3) By ZFN (Zinc Finger Nucleases): Custom ZFNs, Commercial ZFN Kits

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2486

What regions are at the forefront of gene editing market expansion?
North America was the largest region in the gene editing market in 2024. Western Europe was the second largest region in the global gene editing market share. The regions covered in the gene editing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Who are the leading players fueling growth in the gene editing market?
Major companies operating in the gene editing market include AstraZeneca plc, Thermo Fisher Scientific Inc., Merck KGaA, GE Healthcare Life Sciences, Agilent Technologies Inc., Lonza Group AG, PerkinElmer Inc., Bio-Rad Laboratories Inc., Qiagen N.V., CRISPR Therapeutics, Promega Corporation, GenScript USA Inc., Integrated DNA Technologies Inc., Intellia Therapeutics Inc., DNA Script Inc., Dharmacon Inc., Precision Biosciences Inc., Editas Medicine Inc., OriGene Technologies Inc., Tecan Group Ltd., Sangamo Therapeutics Inc., Horizon Discovery Group plc, Addgene Inc., New England Biolabs Inc., Cellectis SA, Recombinetics Inc., Allele Biotechnology LLC, Transposagen Biopharmaceuticals Inc., Bluebird Bio Inc., Regeneron Pharmaceuticals Inc., Amsbio LLC, Creative Biogene Inc., Synthego Corporation, Beam Therapeutics Inc., Caribou Biosciences Inc., Inscripta Inc., Mammoth Biosciences Inc., Sangon Biotech (Shanghai) Co. Ltd., ToolGen Inc., Mirus Bio LLC

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=2486&type=smp

What Is Covered In The Gene Editing Global Market Report?

•Market Size Forecast: Examine the gene editing market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the gene editing market for a structured understanding.
•Key Players Overview: Analyze major players in the gene editing market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the gene editing market.
•Segment Contributions: Evaluate how different segments drive overall growth in the gene editing market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the gene editing market.
•Industry Challenges: Identify potential risks and obstacles affecting the gene editing market.
•Competitive Landscape: Review strategic developments in the gene editing market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.